February 29, 2016
Nexstim Plc Receives Interim Analysis Information and Recommendation from DSMB for Phase III Stroke Therapy Trial
Media
February 26, 2016
NORDIC NANOVECTOR ASA: FOURTH QUARTER AND FULL YEAR 2015 RESULTS; OPERATIONS ON TRACK
February 25, 2016
Strongbridge Biopharma plc Announces Presentations at Two Upcoming Investor Conferences
February 25, 2016
Cerenis Therapeutics featured prominently at the 25th Conference of the ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL)
February 18, 2016
Strongbridge Biopharma plc Announces Participation at SunTrust Robinson Humphrey’s 2016 Orphan Drug Day
February 16, 2016
Cash position and revenue for 2015
February 02, 2016
Q4 2015 General Market Overview
February 02, 2016
Targovax submits a study of its adenovirus based immune therapy ONCOS-102 to the regulatory authorities in Spain
February 01, 2016
NORDIC NANOVECTOR AWARDED NOK 15 MILLION FROM THE RESEARCH COUNCIL OF NORWAY TO RESEARCH AND DEVELOP NOVEL TARGETED THERAPEUTICS
January 28, 2016
Full year report January-December 2015